Home › Schizophrenia › Oklahoma
Schizophrenia clinical trials in Oklahoma
4 studies for Schizophrenia are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0047, Oklahoma City
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Sooner Clinical Research, Oklahoma City
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- The Rivus Wellness & Research Institute, Oklahoma City
- Local Institution - 0052, Tulsa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Oklahoma City
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.